MIRA Pharmaceuticals Management
Management criteria checks 0/4
MIRA Pharmaceuticals' CEO is Erez Aminov, appointed in Apr 2023, has a tenure of 1.08 years. total yearly compensation is $1.71M, comprised of 4.9% salary and 95.1% bonuses, including company stock and options. directly owns 2.53% of the company’s shares, worth $317.47K. The average tenure of the management team and the board of directors is 1.1 years and 0.2 years respectively.
Key information
Erez Aminov
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 4.9% |
| CEO tenure | 1.1yrs |
| CEO ownership | 2.5% |
| Management average tenure | 1.1yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$12m |
| Dec 31 2023 | US$2m | US$83k | -US$12m |
Compensation vs Market: Erez's total compensation ($USD1.71M) is above average for companies of similar size in the US market ($USD661.60K).
Compensation vs Earnings: Insufficient data to compare Erez's compensation with company performance.
CEO
Erez Aminov (44 yo)
1.1yrs
Tenure
US$1,705,647
Compensation
Mr. Erez Aminov is Chief Executive Officer of MIRA Pharmaceuticals, Inc. from April 28, 2023 and has been its Director since May 2022 and serves as its Chairman of the Board since March 2024. Mr. Aminov is...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 1.1yrs | US$1.71m | 2.53% $ 317.5k | |
| CFO, Secretary & Treasurer | 1.1yrs | US$620.99k | 0% $ 0 | |
| Chief Scientific Advisor | less than a year | no data | no data |
1.1yrs
Average Tenure
Experienced Management: MIRA's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 2yrs | US$1.71m | 2.53% $ 317.5k | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
0.2yrs
Average Tenure
41yo
Average Age
Experienced Board: MIRA's board of directors are not considered experienced ( 0.2 years average tenure), which suggests a new board.